Revisions to Research Objectives in PA-08-267, Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21)

Notice Number: NOT-CA-09-008

Key Dates
Release Date: January 7, 2009

Issued by
National Cancer Institute (NCI) (http://www.cancer.gov)

The purpose of this Notice is to clarify and revise the Research Objectives in PA-08-267,Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21).

A. Part II – Full text of Announcement; Section I. Funding Opportunity Description; 1. Research Objectives; Background.  The following text has been added:

Applications focused on imaging research are not appropriate for this announcement.  However, applications involving studies that are focused on the development of diagnostic, prognostic, and/or predictive markers and that contain a very minor non-human imaging component are appropriate.

B. 1. Part II – Full text of Announcement; Section I. Funding Opportunity Description; 1. Research Objectives; Specific Research Objectives. The following correction has been made:

The subtitle “Appropriate topics for pilot human nutrition research and/or validation studies under this initiative include, but are not limited to, the following examples:”

Should correctly read

“Appropriate topics for pilot research and/or validation studies utilizing biospecimens from human subjects or human cell lines under this initiative include, but are not limited to, the following examples:”

In addition, the word “nutrition” should not have been in that sentence and has been deleted; studies specifically related to nutrition are not appropriate for this funding opportunity.

Inquiries

Inquiries regarding this Notice may be directed to:

James V. Tricoli, Ph.D.
Cancer Diagnosis Program
Division of Cancer Treatment and Diagnosis (DCTD)
National Cancer Institute (NCI)
6130 Executive Boulevard, EPN Room 6031A, MSC 7420
Bethesda, MD 20892-7420 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for non-U.S.P.S. delivery)
Telephone: (301) 496-1591
Fax: (301) 402-7819
E-mail: [email protected]